2026 NPPES data Dermatology Physician NPI 1730455320 M.D.
Verify on CMS →

MARILYN ZABIELINSKI, M.D.

Dermatology Physician in MOUNTAIN BRK, Alabama. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
273
Medicare Part D claims · 54 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$545.35
13 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARILYN ZABIELINSKI, M.D. filed 273 Medicare Part D claims in 2023 as a Dermatology Physician in MOUNTAIN BRK, Alabama, prescribing 90% generic.

273
Part D claims, 2023
90%
generic prescribing
$545.35
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARILYN ZABIELINSKI, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

273 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

MARILYN ZABIELINSKI, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARILYN ZABIELINSKI, M.D.?

Quality data not reported

NPI registry status

Active

Issued 03/28/2012

NPI 1730455320

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

273 63% vs specialty avg

2023 prescription claims

Specialty avg: 729

Specialty distribution in Alabama

How Dermatology Physician compares to other specialties among Alabama providers

Alabama providers

Dermatology Physician share within Alabama

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Alabama

Specialty board-certification context

Estimated specialty board-certified rate — Dermatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Dermatology Physician ABMS/AOA estimate

Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARILYN ZABIELINSKI, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 201 OFFICE PARK DR STE 350, MOUNTAIN BRK, AL, 35223, with a listed phone of (205) 870-3303. NPI 1730455320 was issued on 03/28/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZABIELINSKI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 273 prescription claims written by this provider, covering 54 Medicare beneficiaries and totaling roughly $40K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

201 OFFICE PARK DR STE 350
MOUNTAIN BRK, AL 35223

Provider Details

NPI 1730455320
Specialty Dermatology Physician
Credentials M.D.
Gender Female
NPI Issued 03/28/2012

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARILYN ZABIELINSKI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$545

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MARILYN ZABIELINSKI, M.D. — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 273 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

273
Total Claims
$40K
Total Drug Cost
54
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
306
Total Day Supply
7,861
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$30K
Generic Drug Cost
$11K

Patient Demographics

Average Patient Age
70.0 years
Avg HCC Risk Score
1.02
Gender Split
74% female / 26% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARILYN ZABIELINSKI, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ketoconazole
46
Ciclopirox
Ciclopirox Olamine
26
Clobetasol Propionate
23
Fluocinonide
21
Jublia
Efinaconazole
19
Triamcinolone Acetonide
18
Hydrocortisone
16
Mupirocin
15
Valacyclovir
Valacyclovir Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How MARILYN ZABIELINSKI, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

MARILYN ZABIELINSKI, M.D.'s 273 claims are below the specialty average of 729.

Nearby Dermatology Physician Providers in Alabama

Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as ZABIELINSKI.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARILYN ZABIELINSKI, M.D.'s specialty?
MARILYN ZABIELINSKI, M.D. specializes in Dermatology Physician and practices in MOUNTAIN BRK, Alabama. Credentials: M.D..
How much does MARILYN ZABIELINSKI, M.D. prescribe under Medicare Part D?
In 2023, MARILYN ZABIELINSKI, M.D. wrote 273 Medicare Part D claims totaling $40K in drug costs for 54 beneficiaries.
Where is MARILYN ZABIELINSKI, M.D. located?
MARILYN ZABIELINSKI, M.D. is located at 201 OFFICE PARK DR STE 350, MOUNTAIN BRK, AL, 35223. Phone: (205) 870-3303.
What is MARILYN ZABIELINSKI, M.D.'s NPI number?
MARILYN ZABIELINSKI, M.D.'s National Provider Identifier (NPI) is 1730455320, issued on 03/28/2012.
Does MARILYN ZABIELINSKI, M.D. prescribe more brand-name or generic drugs?
MARILYN ZABIELINSKI, M.D.'s prescribing is 10% brand-name and 90% generic drugs by claim count, with $30K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does MARILYN ZABIELINSKI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARILYN ZABIELINSKI, M.D.'s most frequently prescribed drugs include Ketoconazole, Ciclopirox, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARILYN ZABIELINSKI, M.D. accept Medicare?
MARILYN ZABIELINSKI, M.D. appears in CMS Medicare data with 273 Part D claims and 54 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARILYN ZABIELINSKI, M.D.'s credentials?
MARILYN ZABIELINSKI, M.D.'s NPI is 1730455320 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology